Goldman Sachs’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-52,242
| Closed | -$11.3M | – | 6812 |
|
|
2021
Q1 | $11.3M | Sell |
52,242
-1,245
| -2% | -$234K | ﹤0.01% | 2455 |
|
|
2020
Q4 | $6.17M | Buy |
53,487
+11,550
| +28% | +$1.29M | ﹤0.01% | 2858 |
|
|
2020
Q3 | $4.08M | Sell |
41,937
-63,087
| -60% | -$7.26M | ﹤0.01% | 3058 |
|
|
2020
Q2 | $12.9M | Buy |
105,024
+2,240
| +2% | +$254K | ﹤0.01% | 2066 |
|
|
2020
Q1 | $9M | Sell |
102,784
-10,814
| -10% | -$1.15M | ﹤0.01% | 2158 |
|
|
2019
Q4 | $11.9M | Buy |
113,598
+11,592
| +11% | +$1.3M | ﹤0.01% | 2307 |
|
|
2019
Q3 | $11.7M | Sell |
102,006
-8,783
| -8% | -$1.33M | ﹤0.01% | 2200 |
|
|
2019
Q2 | $19.1M | Sell |
110,789
-28,068
| -20% | -$4.85M | 0.01% | 1890 |
|
|
2019
Q1 | $23.4M | Sell |
138,857
-35,457
| -20% | -$5.28M | 0.01% | 1740 |
|
|
2018
Q4 | $17M | Buy |
174,314
+58,595
| +51% | +$7.69M | 0.01% | 1936 |
|
|
2018
Q3 | $20M | Buy |
115,719
+89,840
| +347% | +$13M | 0.01% | 1923 |
|
|
2018
Q2 | $3.61M | Sell |
25,879
-84,227
| -76% | -$12M | ﹤0.01% | 3193 |
|
|
2018
Q1 | $12.4M | Buy |
110,106
+1,593
| +1% | +$200K | ﹤0.01% | 2175 |
|
|
2017
Q4 | $14.3M | Buy |
108,513
+23,571
| +28% | +$2.77M | ﹤0.01% | 2182 |
|
|
2017
Q3 | $8.62M | Buy |
84,942
+36,383
| +75% | +$3.9M | ﹤0.01% | 2686 |
|
|
2017
Q2 | $4.87M | Buy |
48,559
+15,816
| +48% | +$1.7M | ﹤0.01% | 3080 |
|
|
2017
Q1 | $3.96M | Sell |
32,743
-211,139
| -87% | -$25.9M | ﹤0.01% | 3136 |
|
|
2016
Q4 | $27.3M | Buy |
243,882
+156,498
| +179% | +$18.8M | 0.01% | 1736 |
|
|
2016
Q3 | $11.6M | Buy |
87,384
+54,969
| +170% | +$5.25M | ﹤0.01% | 2332 |
|
|
2016
Q2 | $2.97M | Buy |
32,415
+23,110
| +248% | +$1.95M | ﹤0.01% | 3277 |
|
|
2016
Q1 | $671K | Sell |
9,305
-68,024
| -88% | -$3.73M | ﹤0.01% | 4453 |
|
|
2015
Q4 | $5.37M | Buy |
77,329
+76,511
| +9,353% | +$6.23M | ﹤0.01% | 2754 |
|
|
2015
Q3 | $75K | Buy |
+818
| New | +$91K | ﹤0.01% | 6632 |
|
|
2015
Q2 | – | Sell |
-4,364
| Closed | -$398K | – | 7517 |
|
|
2015
Q1 | $398K | Sell |
4,364
-11,891
| -73% | -$966K | ﹤0.01% | 5360 |
|
|
2014
Q4 | $1.1M | Buy |
16,255
+13,343
| +458% | +$975K | ﹤0.01% | 4465 |
|
|
2014
Q3 | $235K | Sell |
2,912
-4,114
| -59% | -$364K | ﹤0.01% | 6009 |
|
|
2014
Q2 | $754K | Buy |
7,026
+4,807
| +217% | +$334K | ﹤0.01% | 4965 |
|
|
2014
Q1 | $132K | Buy |
+2,219
| New | +$132K | ﹤0.01% | 6292 |
|
Other funds holding GWPH
Goldman Sachs's GWPH Position: Q2 2021 in Review
Goldman Sachs sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 52,242 shares — an estimated $11.3M sold.
Goldman Sachs first reported a position in GWPH in Q1 2014 and held it in 28 quarters. The position peaked at $27.3M in Q4 2016. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Goldman Sachs reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Goldman Sachs sold 52,242 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $11.3M.
- Goldman Sachs first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 28 quarters.
- Goldman Sachs's GW Pharmaceuticals Plc American Depositary Shares position peaked at $27.3M in Q4 2016.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.